Gendius’ Intellin® platform uses artificial intelligence to actively monitor patients’ diabetes management and uses their clinical history to highlight their risk for developing diabetes-related complications, such as cardiovascular disease, kidney disease, amputation, and blindness. Its algorithms analyse users’ health and wellbeing data to provide individually tailored, clinically-validated educational content and guidance to help people with diabetes to manage their condition more effectively.